These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 37201875)
1. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists. Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875 [TBL] [Abstract][Full Text] [Related]
2. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy. Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711 [TBL] [Abstract][Full Text] [Related]
4. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548 [TBL] [Abstract][Full Text] [Related]
5. Cancer Immunotherapy Based on Cell Membrane-Coated Nanocomposites Augmenting cGAS/STING Activation by Efferocytosis Blockade. Chen Z; Li Z; Huang H; Shen G; Ren Y; Mao X; Wang L; Li Z; Wang W; Li G; Zhao B; Guo W; Hu Y Small; 2023 Oct; 19(43):e2302758. PubMed ID: 37381095 [TBL] [Abstract][Full Text] [Related]
6. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy. Li A; Yi M; Qin S; Song Y; Chu Q; Wu K J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414 [TBL] [Abstract][Full Text] [Related]
7. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases. Zhou S; Cheng F; Zhang Y; Su T; Zhu G Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125 [TBL] [Abstract][Full Text] [Related]
8. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies. Zhang J; Yu S; Peng Q; Wang P; Fang L Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538 [TBL] [Abstract][Full Text] [Related]
9. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy. Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711 [TBL] [Abstract][Full Text] [Related]
10. Targeting STING for cancer immunotherapy: From mechanisms to translation. Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492 [TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
12. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity. Tabar MMM; Fathi M; Kazemi F; Bazregari G; Ghasemian A Mol Biol Rep; 2024 Apr; 51(1):487. PubMed ID: 38578532 [TBL] [Abstract][Full Text] [Related]
13. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity. Shen Q; Xu P; Mei C Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467 [TBL] [Abstract][Full Text] [Related]
14. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway. García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080 [TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of cGAS in Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345 [TBL] [Abstract][Full Text] [Related]
16. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy. Cao L; Tian H; Fang M; Xu Z; Tang D; Chen J; Yin J; Xiao H; Shang K; Han H; Li X Biomaterials; 2022 Nov; 290():121856. PubMed ID: 36306685 [TBL] [Abstract][Full Text] [Related]
17. Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology. Kumar V; Bauer C; Stewart JH Eur J Cell Biol; 2023 Sep; 102(3):151338. PubMed ID: 37423035 [TBL] [Abstract][Full Text] [Related]
18. cGAS-STING signaling in cancer immunity and immunotherapy. Du H; Xu T; Cui M Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable Long-Circulating Nanoagonists Optimize Tumor-Tropism Chemo-Metalloimmunotherapy for Boosted Antitumor Immunity by Cascade cGAS-STING Pathway Activation. Li H; Zhang C; Chen Y; Xu Y; Yao W; Fan W ACS Nano; 2024 Aug; 18(34):23711-23726. PubMed ID: 39148423 [TBL] [Abstract][Full Text] [Related]
20. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy. Luo K; Li N; Ye W; Gao H; Luo X; Cheng B Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]